Health – US rejects international testing rules

If you’re a cat, watch a video of a cat fighting a coyote on a porch and holding on to itself.

Today, in healthcare, you will not need a negative COVID-19 test to enter the US by air. We will immerse ourselves in the decision.

Welcome to the Night Health Service, where we are following the latest developments in policies and news affecting your health. In The Hill we are Peter Sullivan, Nathaniel Weixel and Joseph Choi. Subscribe here.

Biden officials end international travel requirement

Another COVID rule in times of crisis is being lifted.

The Biden administration announced on Friday that it was ending the requirement for international travelers to test for a negative coronavirus before coming to the United States.

  • The Centers for Disease Control and Prevention (CDC) has “determined on the basis of science and data that this condition is not necessary at this time,” a senior administration official said.
  • The condition ends at 12:01 a.m. Sunday.

Between the lines: Some experts noted that the requirement did not meet the target, as COVID-19 is already widely circulated in the United States and the land border crossings are not subject to the same conditions.

The travel industry also lobbied to remove the requirement, saying it was no longer necessary.

A sign of a new era: The move is another sign of a new stage in COVID-19, where some measures designed when the virus was seen to be in a terrible crisis are being repealed.

  • “We are able to take this step because of the tremendous progress we have made in the fight against the virus: we have made life-saving vaccines and treatments available, and these tools are working to prevent serious illness and death, and they are effective. senior officials of your administration.

Read more here.

ANIMATE THE TRAVEL INDUSTRY

Airlines and travel groups were encouraged by the Biden administration’s decision to remove the requirement for the COVID-19 test for air travelers entering the U.S., a long-standing victory for the industry.

Lobbying follows a blitz: Travel and tourism interests have been pressuring the White House for months to remove the requirement in a series of meetings, letters and opinion pieces. They argued that the rules were detrimental to travel demand and noted that other countries, such as the United Kingdom and France, had already removed similar restrictions.

“Removing this policy will help promote and revive air travel to the United States by benefiting communities across the country that support local economies that rely heavily on travel and tourism across the country,” said Nicholas Calio, president of Airlines for America, representing a trade group. Major U.S. carriers said in a statement.

“We look forward to welcoming millions of travelers to the United States for vacation, business, and family reunion.”

The travel industry presented the Biden administration with a potential economic growth to remove the test requirement. The U.S. Travel Association released an analysis this month that the change could increase U.S. travel spending by 12 percent, bringing in an additional $ 9 billion.

Read more here.

The Fed is buying 500K more doses of vaccine to fight the monkey flu

Health officials said Friday that the White House had ordered an additional 500,000 doses of the monkey vaccine.

  • The doses of the Jynneos smallpox vaccine are liquid and frozen, according to Dawn O’Connell, the assistant secretary of health and human services (HHS) for preparation and response, said at a news conference.
  • Although there are currently no vaccines or antivirals specifically designed to treat monkeys, the Food and Drug Administration (FDA) has authorized Jynneos to be used in adults to prevent monkey infections.

The order, which was announced on Friday, is expected to be delivered later this year.

Current supply: O’Connell also noted that the U.S. National Strategic Repository (SNS) currently has 72,000 doses of Jynneos in its immediate inventory and expects to reach 300,000 more in the coming weeks.

The drug was created by Bavarian Nordic, a biotechnology company headquartered in Denmark.

  • The SNS also has more than 100 million doses of the ACAM2000 smallpox vaccine, although health officials have indicated that it has been a priority for Jynneos.
  • The ACAM2000 vaccine is older and has some side effects that may cause the provider to worry, including muscle aches, rashes, and nausea.

Read more here.

THE MILITARY HAS CONFIRMED ITS FIRST CASE OF TXIMINO BARRIZOLA

The Pentagon on Friday confirmed the first known case of the U.S. military monkey.

  • A member of the German-based active service recently tested positive for the virus, a Defense Department spokesman confirmed to The Hill.
  • NBC News, which first reported the case, said the unidentified person was seen and treated at the Stuttgart Army Health Clinic and is now isolated at their headquarters.

What they say: Army Captain William Speaks, a spokesman for the U.S. European Command, told NBC that public health officials found the risk to the general population to be “very low,” as the case is part of the West African strain, which is generally light-hearted. limited human transmission.

He added that contacts are being made for clinic staff who see the patient as a “precautionary measure”.

The CDC has stressed that the virus – spread through long-lasting skin contact or through contaminated tissues such as clothing or bed sheets – is not a major risk to the public.

Read more here.

CDC data show a new overlap

Reports of an increase in substance use in recent years and an increase in rates of mental health disorders are not new, mainly because Americans were struggling with the economic and humanistic toll of the COVID-19 pandemic.

But data released by the Centers for Disease Control and Prevention (CDC) on Friday document the extent to which these two conditions overlap.

According to the Center’s latest Morbidity and Mortality Weekly Report, 2019 at least one-third of adults they reported serious psychiatric problems that assessed substance use in treatment centers.

Although current data were collected before the COVID-19 pandemic, the authors stated that future research will focus on the impact of the crisis on trends.

  • In 2019, more than 65 million adults experienced drunkenness and more than 35 million used illicit drugs in the past month, the authors said, highlighting that people with substance use disorders are at higher risk for overdoses and other ill health outcomes. .
  • A total of 49,138 people were evaluated at 339 treatment centers in 37 states. All people were at least 18 years old, and the most commonly used substances in the last month were alcohol, followed by cannabis, misuse of prescription opioids, and illegal stimulants, among others.

Read more here.

WE ARE READING

  • Are these hamsters who love Cocoa Krispies the key to turning on the long Covid? (Statistics)
  • Report reveals significant increase in transgender youth in the US (New York Times)
  • Some Monkeypox patients also have sexually transmitted diseases, according to the CDC (CNBC).

STATE BY STATE

  • Core groups move to close Colorado children’s death toll (Kaiser Health News)
  • “Don’t Go”: Northeast Florida COVID-19 Case Increases Hospitalization (News4Jax)
  • Oklahoma Abortion Act raises questions about NCAA Softball World Series (The New York Times)

That’s it for today, thanks for reading. Check out The Hill’s Health Care page for the latest news and coverage. Until next Tuesday.

SEE THE FULL EDITION HERE

.

Leave a Comment